-
The ‘Magnificent Seven’ companies just did something they haven’t in two years. Goldman says it’s time to make a shift.
Goldman Sachs finds an oddity under the hood of earnings season when it comes to major technology companies.MarketWatch - 1h -
This HR Company Valued at $12 Billion Just Announced Plans to IPO. Here’s Why Other Companies Are Watching Closely
Human Resources startup Deel recently hit an annual revenue run rate of $800 million.Inc. - 2d -
Connor Bedard Climbs Higher on Teenager Points List
Connor Bedard just continues to produce offensively on his recent tear.Yahoo Sports - 22h -
The Hater Bowl: Some fans just can't stand ... anything
Haters are going to hate both the Philadelphia Eagles and the Kansas City Chiefs as they shake it into the Superdome in New Orleans on Sunday.NBC News - 2d -
Many workers would take a pay cut to work from home — some would forgo at least 20% of their salary
Workers cite the work-life balance afforded by hybrid or fully remote jobs as the biggest benefit.CNBC - 2d -
As the war on DEI intensifies, some companies hold the line while others work behind the scenes
Trump's hostility toward DEI has elevated the stakes for corporations already grappling with how to navigate the principles of diversity, equity and inclusion.CNBC - 2d -
Travis Kelce Just Taught a Powerful Lesson in How to Strengthen a Team. Every Leader Should Pay Attention
The Kansas City Chiefs tight end says he loves that the team is ‘the villains of the NFL.’Inc. - 3d -
EV Sales Climb in Spite of Automaker Losses and Trump-Related Uncertainty
Ford’s EV unit lost billions of dollars, but at the same time, EV sales as a whole were up in the U.S. in 2024 compared to the year before.Inc. - 3d -
Trump’s Attacks on DEI Get Approval From Some in the Left Wing
Many Democrats and activists are rallying to defend diversity programs, but others say they distract from deeper efforts to address inequality.The New York Times - 3d
More from Inc.
-
Patrick Mahomes Kept Blaming One Person for the Chiefs’ Brutal Super Bowl Loss. It’s a Lesson in Emotional Intelligence
You could point the finger at lots of people for the Chiefs’ crushing loss in last night’s Super Bowl. Patrick Mahomes is only pointing it at one.Inc. - 1h -
Unlocking Leadership Potential: Mastering the Art of Delegation
Gallup found that CEOs with high delegator talent also generated 33 percent greater revenue than those with low or limited levels of the talent.Inc. - 1h -
FOX’s Most Divisive Super Bowl Decision Made Everyone Mad
The broadcaster rolled out a new score bug and no one was happy.Inc. - 2h -
Galentine’s Day, pet gifts, and acknowledging failure: How founder and CEO Jim McCann is navigating Valentine’s Day at 1-800-Flowers.com
As his company gears up for its own “Super Bowl,” McCann shares his insights on running his company through good times, tech glitches, and failures.Inc. - 3h -
What Forerunner Ventures Looks for in Consumer Startups: Vision, Magnetism, and Unfair Advantages
Partner Nicole Johnson shares her outlook for consumer brands and where she’s looking to invest in 2025.Inc. - 3h
More in Business
-
Consumer Financial Protection Bureau staff told to work remotely as headquarters is shuttered
CFPB employees were told Sunday to work remotely because their Washington, D.C., headquarters would be closed through Feb. 14, according to a memo.CNBC - 8m -
Musk calls to impeach judge whose order blocks DOGE from Treasury systems access
Musk wants to impeach a federal judge after an order temporarily restricts his team from accessing the Treasury Department's payment systems and sensitive data.CNBC - 12m -
The Best and Worst Super Bowl Commercials, Ranked
Here is our critic’s survey of this year’s Super Bowl commercials, from best to worst.The New York Times - 14m -
Fox Acquires Firm Behind Conservative and True Crime Podcasts
Tucker Carlson, Nancy Grace, Megyn Kelly and Piers Morgan are among the clients of Red Seat Ventures, which now joins Rupert Murdoch’s empire.The New York Times - 15m -
Trump is unlikely to end Medicare drug price talks — here's what that means for patients and pharma
Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper savings to outdo his predecessor.CNBC - 26m